AZELEX
Clinical safety rating: caution
Comprehensive clinical and safety monograph for AZELEX (AZELEX).
Azelaic acid inhibits microbial protein synthesis and reduces the proliferation of Propionibacterium acnes. It also normalizes keratinization and has anti-inflammatory effects by scavenging free radicals.
| Metabolism | Azelaic acid is primarily metabolized via beta-oxidation in the liver to suberic acid and pimelic acid. Minor pathways include conjugation with glycine and glucuronic acid. |
| Excretion | Primarily renal (~60% as unchanged drug and metabolites) and biliary/fecal (~40%). |
| Half-life | Terminal elimination half-life is approximately 1-2 hours in patients with normal renal function; prolonged to 3-4 hours in renal impairment. |
| Protein binding | Azelaic acid is approximately 95% bound to plasma proteins, primarily albumin. |
| Volume of Distribution | Vd is approximately 0.6 L/kg, indicating distribution primarily in total body water. |
| Bioavailability | After topical application, systemic absorption is minimal (approximately 4% of applied dose). |
| Onset of Action | Topical: clinical improvement in acne vulgaris typically seen within 4-6 weeks of twice-daily application. |
| Duration of Action | Duration of therapeutic effect after discontinuation is not well-defined; continuous use is recommended for maintenance. |
Apply a thin layer to affected areas twice daily (morning and evening) or as directed by a physician. Topical use only.
| Dosage form | CREAM |
| Renal impairment | No dosage adjustment required for renal impairment. |
| Liver impairment | No dosage adjustment required for hepatic impairment. |
| Pediatric use | Safety and efficacy in pediatric patients below 12 years of age have not been established. |
| Geriatric use | No specific geriatric dosage adjustment provided; use with caution due to potential for increased skin sensitivity. |
| 1st trimester | Consult provider |
| 2nd trimester | Consult provider |
| 3rd trimester | Consult provider |
Clinical note
Comprehensive clinical and safety monograph for AZELEX (AZELEX).
| Breastfeeding | Unknown if excreted in human milk; M/P ratio not available. Caution advised due to potential for infant skin irritation. |
| Teratogenic Risk | No teratogenic effects in animal studies; limited human data. Topical absorption minimal, but risk not excluded. Use only if clearly needed during first trimester. |
| Fetal Monitoring | No specific fetal monitoring required; observe for maternal skin irritation or systemic effects. Routine obstetric care. |
■ FDA Black Box Warning
None.
| Serious Effects |
["Hypersensitivity to azelaic acid or any component of the formulation."]
| Precautions | ["Hypopigmentation: use with caution in patients with dark skin as reversible hypopigmentation may occur.","Irritation: local skin reactions (e.g., erythema, scaling, burning) may occur; discontinue if severe.","Foreign body granuloma: rare cases reported with topical use."] |
| Food/Dietary | No specific food interactions have been reported with Azelex. However, alcohol and spicy foods may exacerbate rosacea symptoms in some patients; consider avoidance if triggers are identified. |
| Clinical Pearls |
Loading safety data…
| Fertility Effects | No known effects on human fertility based on available data. |
| Azelex (azelaic acid 20% cream) is a first-line topical therapy for mild-to-moderate papulopustular rosacea and acne vulgaris. It has anti-inflammatory and antibacterial properties, suppressing reactive oxygen species and inhibiting microbial protein synthesis. Avoid use on broken skin or mucous membranes. Apply twice daily; therapeutic response may take 4–8 weeks. Can be combined with other topical retinoids or antibiotics. Hypopigmentation risk in dark-skinned patients is rare but monitor. |
| Patient Advice | Wash and dry the affected skin area before applying a thin layer of cream twice daily. · Avoid contact with eyes, mouth, and other mucous membranes. · Expect initial skin irritation (redness, itching, stinging) that usually subsides with continued use. · Use sunscreen and protective clothing as Azelex can make skin more sensitive to UV light. · Do not use occlusive dressings over the treated area. · Report any signs of allergic reaction (hives, difficulty breathing) or severe irritation. · Inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding. · Continue use even if improvement is slow; it may take 4 weeks to see results. |